The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2023 - external site, which commenced on 3 July 2023. This determination replaces the previous instrument, the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2023.
This instrument is updated frequently and there may be a more recent version of the instrument. Ensure you are accessing the current version of the instrument through the Therapeutic Goods Determination page.
A complete list of the 5 changed ingredients is below.
Changed ingredients
|
Substance name |
Change |
|---|---|
|
Refined Buglossoides arvensis seed oil |
Addition |
|
Chicken sternum cartilage powder |
Addition |
|
Change of name from Saccharomyces cervisiae polysaccharides to Saccharomyces cerevisiae polysaccharides |
Change |
|
Violet leaf absolute |
Change |
|
Poloxamine 1301 |
Removal |